skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: How Informative Are Drug-Drug Interactions of Gene-Drug Interactions?: Drug- and Gene-Drug Interactions

Authors:
 [1];  [1];  [1];  [2];  [2];  [1]
  1. Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida at Lake Nona, Orlando FL, USA
  2. FDA Genomics and Targeted Therapy Group, Office of Clinical Pharmacology, Office of Translational Sciences, CDER, US FDA, Silver Spring MD, USA
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1400958
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
Journal of Clinical Pharmacology
Additional Journal Information:
Journal Name: Journal of Clinical Pharmacology Journal Volume: 56 Journal Issue: 10; Journal ID: ISSN 0091-2700
Publisher:
Wiley Blackwell (John Wiley & Sons)
Country of Publication:
United States
Language:
English

Citation Formats

Lagishetty, Chakradhar V., Deng, Jiexin, Lesko, Lawrence J., Rogers, Hobart, Pacanowski, Michael, and Schmidt, Stephan. How Informative Are Drug-Drug Interactions of Gene-Drug Interactions?: Drug- and Gene-Drug Interactions. United States: N. p., 2016. Web. doi:10.1002/jcph.743.
Lagishetty, Chakradhar V., Deng, Jiexin, Lesko, Lawrence J., Rogers, Hobart, Pacanowski, Michael, & Schmidt, Stephan. How Informative Are Drug-Drug Interactions of Gene-Drug Interactions?: Drug- and Gene-Drug Interactions. United States. doi:10.1002/jcph.743.
Lagishetty, Chakradhar V., Deng, Jiexin, Lesko, Lawrence J., Rogers, Hobart, Pacanowski, Michael, and Schmidt, Stephan. Tue . "How Informative Are Drug-Drug Interactions of Gene-Drug Interactions?: Drug- and Gene-Drug Interactions". United States. doi:10.1002/jcph.743.
@article{osti_1400958,
title = {How Informative Are Drug-Drug Interactions of Gene-Drug Interactions?: Drug- and Gene-Drug Interactions},
author = {Lagishetty, Chakradhar V. and Deng, Jiexin and Lesko, Lawrence J. and Rogers, Hobart and Pacanowski, Michael and Schmidt, Stephan},
abstractNote = {},
doi = {10.1002/jcph.743},
journal = {Journal of Clinical Pharmacology},
number = 10,
volume = 56,
place = {United States},
year = {2016},
month = {4}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
DOI: 10.1002/jcph.743

Citation Metrics:
Cited by: 3 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

CYP2D6 Genotype Information to Guide Pimozide Treatment in Adult and Pediatric Patients: Basis for the US Food and Drug Administration’s New Dosing Recommendations
journal, September 2012

  • Rogers, Hobart L.; Bhattaram, Atul; Zineh, Issam
  • The Journal of Clinical Psychiatry, Vol. 73, Issue 09
  • DOI: 10.4088/JCP.11m07572

DrugBank: a knowledgebase for drugs, drug actions and drug targets
journal, November 2007

  • Wishart, David S.; Knox, Craig; Guo, An Chi
  • Nucleic Acids Research, Vol. 36, Issue suppl_1
  • DOI: 10.1093/nar/gkm958

Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19
journal, May 2012

  • Zvyaga, Tatyana; Chang, Shu-Ying; Chen, Cliff
  • Drug Metabolism and Disposition, Vol. 40, Issue 9
  • DOI: 10.1124/dmd.112.045575

Consistency of drug–drug and gene–drug interaction information in US FDA-approved drug labels
journal, January 2013

  • Conrado, Daniela J.; Rogers, Hobart L.; Zineh, Issam
  • Pharmacogenomics, Vol. 14, Issue 2
  • DOI: 10.2217/pgs.12.203

PBPK Model Describes the Effects of Comedication and Genetic Polymorphism on Systemic Exposure of Drugs That Undergo Multiple Clearance Pathways
journal, February 2014

  • Vieira, M. d. L. T.; Kim, M-J; Apparaju, S.
  • Clinical Pharmacology & Therapeutics, Vol. 95, Issue 5
  • DOI: 10.1038/clpt.2014.43

In Vivo Quantitative Prediction of the Effect of Gene Polymorphisms and Drug Interactions on Drug Exposure for CYP2C19 Substrates
journal, January 2013

  • Goutelle, Sylvain; Bourguignon, Laurent; Bleyzac, Nathalie
  • The AAPS Journal, Vol. 15, Issue 2
  • DOI: 10.1208/s12248-012-9431-9

The Simcyp Population Based Simulator: Architecture, Implementation, and Quality Assurance
journal, June 2013

  • Jamei, Masoud; Marciniak, Steve; Edwards, Duncan
  • In Silico Pharmacology, Vol. 1, Issue 1
  • DOI: 10.1186/2193-9616-1-9

Quantitative Prediction of Cytochrome P450 (CYP) 2D6-Mediated Drug Interactions
journal, January 2011


A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
journal, March 2009

  • Juurlink, D. N.; Gomes, T.; Ko, D. T.
  • Canadian Medical Association Journal, Vol. 180, Issue 7
  • DOI: 10.1503/cmaj.082001

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
journal, September 2009


PhRMA Survey of Pharmacogenomic and Pharmacodynamic Evaluations: What Next?
journal, April 2012

  • Grecco, N.; Cohen, N.; Warner, A. W.
  • Clinical Pharmacology & Therapeutics, Vol. 91, Issue 6
  • DOI: 10.1038/clpt.2011.334

Positive clinical response to clopidogrel is independent of paraoxonase 1 Q192R and CYP2C19 genetic variants
journal, February 2014

  • Martínez-Quintana, Efrén; Medina-Gil, José M.; Rodríguez-González, Fayna
  • The Journal of Clinical Pharmacology, Vol. 54, Issue 8
  • DOI: 10.1002/jcph.275

The Simcyp ® Population-based ADME Simulator
journal, February 2009

  • Jamei, Masoud; Marciniak, Steve; Feng, Kairui
  • Expert Opinion on Drug Metabolism & Toxicology, Vol. 5, Issue 2
  • DOI: 10.1517/17425250802691074

The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary
journal, March 2011

  • Bell, Alan D.; Roussin, André; Cartier, Raymond
  • Canadian Journal of Cardiology, Vol. 27, Issue 2
  • DOI: 10.1016/j.cjca.2010.12.033

Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin
journal, January 2008

  • Gilard, Martine; Arnaud, Bertrand; Cornily, Jean-Christophe
  • Journal of the American College of Cardiology, Vol. 51, Issue 3
  • DOI: 10.1016/j.jacc.2007.06.064

PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19
journal, January 2012


Comparison of Omeprazole and Pantoprazole Influence on a High 150-mg Clopidogrel Maintenance Dose
journal, September 2009

  • Cuisset, Thomas; Frere, Corinne; Quilici, Jacques
  • Journal of the American College of Cardiology, Vol. 54, Issue 13
  • DOI: 10.1016/j.jacc.2009.05.050

Quantitative Prediction of the Impact of Drug Interactions and Genetic Polymorphisms on Cytochrome P450 2C9 Substrate Exposure
journal, January 2013

  • Castellan, Anne-Charlotte; Tod, Michel; Gueyffier, François
  • Clinical Pharmacokinetics, Vol. 52, Issue 3
  • DOI: 10.1007/s40262-013-0031-3

Clinical Pharmacokinetics and Pharmacodynamics of Clopidogrel
journal, January 2015

  • Jiang, Xi-Ling; Samant, Snehal; Lesko, Lawrence J.
  • Clinical Pharmacokinetics, Vol. 54, Issue 2
  • DOI: 10.1007/s40262-014-0230-6